[Mol Oncol. 2021] Genome-scale CRISPR screening identifies cell cycle and protein ubiquitination processes as druggable targets for erlotini

Genome-scale CRISPR screening identifies cell cycle and protein ubiquitination processes as druggable targets for erlotinib-resistant lung cancer.

Lee J, Choi A, Cho SY, Jun Y, Na D, Lee A, Jang G, Kwon JY, Kim J, Lee S, Lee C.

Mol Oncol. 2021 Feb;15(2):487-502. doi: 10.1002/1878-0261.12853. Epub 2020 Nov 28.PMID: 33188726

https://pubmed.ncbi.nlm.nih.gov/33188726/